@article {NAKAMURA285, author = {NORIO NAKAMURA and IKUYO NARITA and TAKESHI FUJITA and REIICHI MURAKAMI and MICHIKO SHIMADA and MASAYUKI NAKAMURA and HIROSHI OSAWA and HIDEAKI YAMABE and KEN OKUMURA and for THE DIABETIC NEPHROPATHY TREATMENT STUDY GROUP}, title = {Factors Associated with Microalbuminuria Remission in Patients with Type 2 Diabetes: Importance of Early Intervention for Microalbuminuric Patients (TSUGARU STUDY)}, volume = {31}, number = {3}, pages = {285--290}, year = {2017}, publisher = {International Institute of Anticancer Research}, abstract = {Aim: The aim of this study was to clarify the rates of remission and progression for microalbuminuria in patients with type 2 diabetes (T2DM); and factors associated with remission and progression of diabetic nephropathy (DN). Patients and Methods: T2DM patients with a urinary albumin excretion (UAE) rate of 30-300 mg/gCr who were attending the medical clinic in the Tsugaru region in Japan were enrolled into this prospective, observational study for 36 months (N=317). We investigated the rate of remission (UAE \<30 mg/g creatinine (Cr); normal albuminuria) and the rate of progression (UAE >=300 mg/gCr; overt proteinuria) 36 months after study registration. Results: The number of patients whose UAE levels were \<30 mg/gCr (DN remission) at 36 months after registration was 64 (27.4\%), and the number of patients whose UAE levels were >=300 mg/gCr (DN progression) at 36 months after registration was 32 (13.7\%). From multiple logistic regression analysis, the sole factor that contributed to remission at 36 months after registration was the UAE levels at registration (OR: 0.99; 95\% CI: 0.98-1.00, p=0.003), and the factors that contributed to progression at 36 months after registration were the levels of UAE (OR: 1.01; 95\% CI: 1.01-1.02, p=0.000) and systolic blood pressure (OR: 0.96; 95\% CI: 0.93-1.00, p=0.033) at registration. Conclusion: Results suggest that patients with less severe microalbuminuria among microalbuminuric patients might more commonly experience DN remission and that earlier intervention is very important for promoting microalbuminuria remission in DN.}, issn = {0258-851X}, URL = {https://iv.iiarjournals.org/content/31/3/285}, eprint = {https://iv.iiarjournals.org/content/31/3/285.full.pdf}, journal = {In Vivo} }